Determination and Comparison of Short-Chain Fatty Acids in Serum and Colon Content Samples: Alzheimer's Disease Rat As a Case Study

Overview

Journal Molecules

Publisher MDPI

Specialty Biology

Date 2020 Dec 9

PMID 33291848

Citations 5

Authors

Lin-Xiu Guo

Yue Tong

Jue Wang

Guo Yin

Hou-Shuang Huang

Long Zeng

Ping Wang

Jun-Peng Li

Kai-Shun Bi

Tie-Jie Wang

Affiliations

Soon will be listed here.

Abstract

Short-chain fatty acids (SCFAs) are the main microbial fermentation products from dietary fibers in the colon, and it has been speculated that they play a key role in keeping healthy in the whole-body. However, differences in SCFAs concentration in the serum and colon samples had attracted little attention. In this study, we have optimized the extract and analysis methods for the determination of ten SCFAs in both serum and colon content samples. Methanol and acetonitrile were chosen for extraction of SCFAs from serum and colon content samples, respectively. Biological samples were collected from Alzheimer's disease rats treated by extract of (Turcz.) Baill (SC-extract) were taken as research objects. The results showed that, the relative peak intensities of SCFAs in the colon content from all groups were quite similar, and the trend was identical in the serum samples. Compared with the values in humans, the ratio of ten SCFAs in rat's colon was similar, while the percent of acetate in rat's serum was significantly higher. For therapy of Alzheimer's disease (AD), SC-extract decreased the concentration of butyrate, 3-Methyvalerate, and caproate in the serum samples towards the trend of normal rats. This study may help our understanding of how SCFAs are transported across colonic epithelium in healthy and diseased organisms.

Citing Articles

Brain-Gut and Microbiota-Gut-Brain Communication in Type-2 Diabetes Linked Alzheimer's Disease.

Momen Y, Mishra J, Kumar N Nutrients. 2024; 16(15).

PMID: 39125436 PMC: 11313915. DOI: 10.3390/nu16152558.

Gut microbiota and its metabolites in Alzheimer's disease: from pathogenesis to treatment.

Zou X, Zou G, Zou X, Wang K, Chen Z PeerJ. 2024; 12:e17061.

PMID: 38495755 PMC: 10944166. DOI: 10.7717/peerj.17061.

Determination of short-chain fatty acids as putative biomarkers of cancer diseases by modern analytical strategies and tools: a review.

Chalova P, Tazky A, Skultety L, Minichova L, Chovanec M, Ciernikova S Front Oncol. 2023; 13:1110235.

PMID: 37441422 PMC: 10334191. DOI: 10.3389/fonc.2023.1110235.

Gut microbiota-derived short-chain fatty acids protect against the progression of endometriosis.

Chadchan S, Popli P, Ambati C, Tycksen E, Han S, Bulun S Life Sci Alliance. 2021; 4(12).

PMID: 34593556 PMC: 8500332. DOI: 10.26508/lsa.202101224.

Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis.

Liu P, Jiang Y, Gu S, Xue Y, Yang H, Li Y BMC Med. 2021; 19(1):159.

PMID: 34233671 PMC: 8265136. DOI: 10.1186/s12916-021-02034-0.

References

Wang H, Wang C, Guo L, Zheng Y, Hu W, Dong T . Simultaneous determination of short-chain fatty acids in human feces by HPLC with ultraviolet detection following chemical derivatization and solid-phase extraction segmental elution. J Sep Sci. 2019; 42(15):2500-2509. DOI: 10.1002/jssc.201900249. View

Herholz K . Acetylcholine esterase activity in mild cognitive impairment and Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2008; 35 Suppl 1:S25-9. DOI: 10.1007/s00259-007-0699-4. View

Perry E . Acetylcholine and Alzheimer's disease. Br J Psychiatry. 1988; 152:737-40. DOI: 10.1192/bjp.152.6.737. View

Bergman E . Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev. 1990; 70(2):567-90. DOI: 10.1152/physrev.1990.70.2.567. View

Zhao T, Mao G, Zhang M, Zou Y, Feng W, Gu X . Enhanced antitumor and reduced toxicity effect of Schisanreae polysaccharide in 5-Fu treated Heps-bearing mice. Int J Biol Macromol. 2013; 63:114-8. DOI: 10.1016/j.ijbiomac.2013.10.037. View

Morrison D, Preston T . Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016; 7(3):189-200. PMC: 4939913. DOI: 10.1080/19490976.2015.1134082. View

Louis P, Flint H . Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol. 2016; 19(1):29-41. DOI: 10.1111/1462-2920.13589. View

Cummings J, Pomare E, Branch W, Naylor C, Macfarlane G . Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut. 1987; 28(10):1221-7. PMC: 1433442. DOI: 10.1136/gut.28.10.1221. View

Tu S, Okamoto S, Lipton S, Xu H . Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease. Mol Neurodegener. 2014; 9:48. PMC: 4237769. DOI: 10.1186/1750-1326-9-48. View

10.

Black S, Doody R, Li H, McRae T, Jambor K, Xu Y . Donepezil preserves cognition and global function in patients with severe Alzheimer disease. Neurology. 2007; 69(5):459-69. DOI: 10.1212/01.wnl.0000266627.96040.5a. View

11.

Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F . From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell. 2016; 165(6):1332-1345. DOI: 10.1016/j.cell.2016.05.041. View

12.

Counillon L, Bouret Y, Marchiq I, Pouyssegur J . Na(+)/H(+) antiporter (NHE1) and lactate/H(+) symporters (MCTs) in pH homeostasis and cancer metabolism. Biochim Biophys Acta. 2016; 1863(10):2465-80. DOI: 10.1016/j.bbamcr.2016.02.018. View

13.

Haug K, Cochrane K, Nainala V, Williams M, Chang J, Jayaseelan K . MetaboLights: a resource evolving in response to the needs of its scientific community. Nucleic Acids Res. 2019; 48(D1):D440-D444. PMC: 7145518. DOI: 10.1093/nar/gkz1019. View

14.

Feldman H, Gauthier S, Hecker J, Vellas B, Subbiah P, Whalen E . A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology. 2001; 57(4):613-20. DOI: 10.1212/wnl.57.4.613. View

15.

Xu M, Yan T, Fan K, Wang M, Qi Y, Xiao F . Polysaccharide of Schisandra Chinensis Fructus ameliorates cognitive decline in a mouse model of Alzheimer's disease. J Ethnopharmacol. 2019; 237:354-365. DOI: 10.1016/j.jep.2019.02.046. View

16.

Zhao X, Liu C, Xu M, Li X, Bi K, Jia Y . Total Lignans of Schisandra chinensis Ameliorates Aβ1-42-Induced Neurodegeneration with Cognitive Impairment in Mice and Primary Mouse Neuronal Cells. PLoS One. 2016; 11(4):e0152772. PMC: 4818042. DOI: 10.1371/journal.pone.0152772. View

17.

Hamilton A, Vasefi M, Tuin C, McQuaid R, Anisman H, Ferguson S . Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model. Cell Rep. 2016; 15(9):1859-65. DOI: 10.1016/j.celrep.2016.04.077. View

18.

Miwa H, Yamamoto M . High-performance liquid chromatographic analysis of serum short-chain fatty acids by direct derivatization. J Chromatogr. 1987; 421(1):33-41. DOI: 10.1016/0378-4347(87)80376-6. View

19.

Kim M, Kang S, Park J, Yanagisawa M, Kim C . Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology. 2013; 145(2):396-406.e1-10. DOI: 10.1053/j.gastro.2013.04.056. View

20.

Gao C, Liu Y, Jiang Y, Ding J, Li L . Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model. Brain Pathol. 2013; 24(3):261-9. PMC: 8029432. DOI: 10.1111/bpa.12116. View